CAELYX

This brand name is authorized in Australia, Austria, Brazil, Canada, Croatia, Cyprus, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Lithuania, Netherlands, New Zealand, Nigeria, Poland, Romania, Singapore, South Africa, Spain, Turkey, UK.

Active ingredients

The drug CAELYX contains one active pharmaceutical ingredient (API):

1	Doxorubicin UNII 82F2G7BL4E - DOXORUBICIN HYDROCHLORIDE
	Doxorubicin is a cytotoxic anthracycline antibiotic obtained from Streptomyces peucetius var. caesius. The exact mechanism of the antitumour activity of doxorubicin is not known. It is generally believed that inhibition of DNA, RNA and protein synthesis is responsible for the majority of the cytotoxic effects.
	Read more about Doxorubicin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
CAELYX Concentrate for solution for infusion	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L01DB01	Doxorubicin	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01D Cytotoxic antibiotics and related substances → L01DB Anthracyclines and related substances
Discover more medicines within L01DB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	4364Q, 5705G, 6249X, 7230M
BR	Câmara de Regulação do Mercado de Medicamentos	514508301159310, 514515100028103
CA	Health Products and Food Branch	02238389
EE	Ravimiamet	1139554, 1139565, 1213221, 1213232
ES	Centro de información online de medicamentos de la AEMPS	96011001
FI	Lääkealan turvallisuus- ja kehittämiskeskus	066111
FR	Base de données publique des médicaments	62362369
GB	Medicines & Healthcare Products Regulatory Agency	204719, 204724, 392345
HK	Department of Health Drug Office	43397, 66647
IL	מִשְׂרַד הַבְּרִיאוּת	7295
LT	Valstybinė vaistų kontrolės tarnyba	1015575, 1015576, 1028060, 1028061, 1055646
NG	Registered Drug Product Database	B4-8252
Switch country to Nigeria in order to find specific presentations of CAELYX
NL	Z-Index G-Standaard	14175126, 14633620
NL	Z-Index G-Standaard, PRK	50008, 58734
NZ	Medicines and Medical Devices Safety Authority	7732
PL	Rejestru Produktów Leczniczych	100112718
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W67977001, W67977002, W67977003, W67977004
SG	Health Sciences Authority	10426P
TR	İlaç ve Tıbbi Cihaz Kurumu	8681413881435
ZA	Health Products Regulatory Authority	32/26/0533